- ISIN US9901429525
Aktuelle News
News Funktionen
Weitere Funktionen
15 Juni 2015
Apricus Biosciences, Inc.
Apricus Biosciences Announces Last Patient Enrolled in RayVa(TM) Phase 2a Clinical Trial for Raynaud’s Phenomenon in Patients With Scleroderma
10 Februar 2014
Apricus Biosciences, Inc.
Apricus and Recordati Sign Exclusive License Agreement to Market Topical Erectile Dysfunction Cream – Vitaros(R) in Spain, Russia, Turkey and Other Global Territories
Apricus Biosciences, Inc.
Apricus and Recordati Sign Exclusive License Agreement to Market Topical Erectile Dysfunction Cream – Vitaros(R) in Spain, Russia, Turkey and Other Global Territories
4 Februar 2014
Apricus Biosciences, Inc.
Apricus Biosciences to Present at the 16th Annual BIO CEO & Investor Conference
Apricus Biosciences, Inc.
Apricus Biosciences to Present at the 16th Annual BIO CEO & Investor Conference
23 Januar 2014
Apricus Biosciences, Inc.
Apricus Biosciences Announces National Phase Approval for Erectile Dysfunction Cream – Vitaros(R) in Belgium
Apricus Biosciences, Inc.
Apricus Biosciences Announces National Phase Approval for Erectile Dysfunction Cream – Vitaros(R) in Belgium
19 Dezember 2013
Apricus Biosciences, Inc.
Apricus Announces National Phase Approval for Erectile Dysfunction Cream – Vitaros(R) in France
Apricus Biosciences, Inc.
Apricus Announces National Phase Approval for Erectile Dysfunction Cream – Vitaros(R) in France
16 Dezember 2013
Apricus Biosciences, Inc.
Apricus Expands Exclusive License Agreement With Its Partner in Germany to Market Vitaros(R) in Additional European Countries
Apricus Biosciences, Inc.
Apricus Expands Exclusive License Agreement With Its Partner in Germany to Market Vitaros(R) in Additional European Countries
11 Dezember 2013
Apricus Biosciences, Inc.
Apricus Elects Kleanthis G. Xanthopoulos, Ph.D. as New Chairman
Apricus Biosciences, Inc.
Apricus Elects Kleanthis G. Xanthopoulos, Ph.D. as New Chairman
25 November 2013
Apricus Biosciences, Inc.
Apricus Biosciences Announces National Phase Approval for Erectile Dysfunction Cream – Vitaros(R) in Italy
Apricus Biosciences, Inc.
Apricus Biosciences Announces National Phase Approval for Erectile Dysfunction Cream – Vitaros(R) in Italy
13 November 2013
Apricus Biosciences, Inc.
Apricus Biosciences Provides Third Quarter 2013 Corporate Update
Apricus Biosciences, Inc.
Apricus Biosciences Provides Third Quarter 2013 Corporate Update
Apricus Biosciences, Inc.
Apricus and Laboratoires Majorelle Sign Exclusive License Agreement to Market Topical Erectile Dysfunction Cream Vitaros(R) in France, Monaco and Certain African Countries
Apricus Biosciences, Inc.
Apricus and Laboratoires Majorelle Sign Exclusive License Agreement to Market Topical Erectile Dysfunction Cream Vitaros(R) in France, Monaco and Certain African Countries
5 November 2013
Apricus Biosciences, Inc.
Apricus Biosciences Announces Third Quarter 2013 Corporate Update Conference Call
Apricus Biosciences, Inc.
Apricus Biosciences Announces Third Quarter 2013 Corporate Update Conference Call
7 Oktober 2013
Apricus Biosciences, Inc.
Apricus Biosciences Announces National Phase Approval for Erectile Dysfunction Cream – Vitaros(R) in Germany
Apricus Biosciences, Inc.
Apricus Biosciences Announces National Phase Approval for Erectile Dysfunction Cream – Vitaros(R) in Germany
9 September 2013
Apricus Biosciences, Inc.
Apricus Biosciences Updates Presentation Time at the 2013 Stifel Nicolaus Healthcare Conference
Apricus Biosciences, Inc.
Apricus Biosciences Updates Presentation Time at the 2013 Stifel Nicolaus Healthcare Conference
4 September 2013
Apricus Biosciences, Inc.
Apricus Biosciences to Present at the 2013 Stifel Nicolaus Healthcare Conference
Apricus Biosciences, Inc.
Apricus Biosciences to Present at the 2013 Stifel Nicolaus Healthcare Conference
29 August 2013
Apricus Biosciences, Inc.
Apricus Biosciences Provides Vitaros(R) Swissmedic Update
Apricus Biosciences, Inc.
Apricus Biosciences Provides Vitaros(R) Swissmedic Update
15 August 2013
Apricus Biosciences, Inc.
Apricus Biosciences Receives National Phase Approvals for Vitaros(R) in Ireland and the Netherlands